RecruitMe Clinical Trial

Acquiring convalescent specimens to isolate and identify potent monoclonal antibodies against COVID-19
Study of People Who Have Recovered from COVID-19 to Isolate Monoclonal Antibodies Against COVID-19
Sponsor:Columbia University
Enrolling:Male and Female Patients
Clinic Visits:1
Age Range:Between 18 and 65 years old
IRB Number:AAAS9517
Contact: Brett Gray: 212-305-1570 / bg2168@cumc.columbia.edu
Additional Study Information:

A study to isolate and determine the antibody response in patients who have recovered from COVID-19 for the development of monoclonal antibodies for prevention and treatment of coronavirus infections. We are doing this study to develop antibodies against coronavirus to prevent and treat diseases like COVID-19. This study will require one study visit for blood draw in order to examine the antibodies created by your cells, using advanced techniques in the laboratory. If you have been diagnosed with COVID-19 and have recovered, you may be eligible for this study. Contact us to find out more.

Do You Qualify?
Are you between the ages of 18-65?YesNo
Have you tested positive for COVID-19?YesNo
Submit
Cancel
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
Brett Gray
Email: bg2168@cumc.columbia.edu
Phone: 212-305-1570